8-K: Alaunos Therapeutics Announces 1-for-10 Reverse Stock Split

Alaunos Therapeutics will implement a 1-for-10 reverse stock split effective July 17, 2024, to consolidate its shares.

Summary

• Alaunos Therapeutics' Board of Directors approved a 1-for-10 reverse stock split of the company's common stock.
• The reverse stock split will be effective on July 17, 2024, at 5:00 p.m. Eastern Time.
• Every 10 shares of issued and outstanding common stock will be combined into 1 share.
• Trading will continue on The Nasdaq Stock Market under the symbol TCRT on a split-adjusted basis starting July 18, 2024, with a new CUSIP number 98973P309.
• The reverse stock split was approved by stockholders at the Annual Meeting on June 6, 2024, with the board having the authority to set the ratio between 1-for-5 and 1-for-15.
• The final ratio of 1-for-10 was approved by the Board on June 26, 2024.
• Equiniti Trust Company is the exchange agent and will provide instructions to stockholders for exchanging pre-split shares for post-split shares.
• Fractional shares will not be issued; instead, shareholders will receive cash based on the closing price of the stock on the day before the effective time.

Sentiment

Score: 6

Explanation: The document is neutral in tone, detailing a planned corporate action. While reverse stock splits can be viewed negatively, this action was previously approved by shareholders and the board, making it an expected event.

Positives

• The reverse stock split was approved by both the stockholders and the Board of Directors.
• The company has engaged an exchange agent to facilitate the process for shareholders.
• Shareholders will receive cash in lieu of fractional shares.

Risks

• Reverse stock splits can sometimes be perceived negatively by the market.
• The stock price may be volatile following the reverse split.

Future Outlook

The company's common stock will trade on a split-adjusted basis starting July 18, 2024.

Management Comments

• The Board of Directors approved the filing of the Third Amended and Restated Certificate of Incorporation to effect the reverse stock split.
• The stockholders granted authority to the Board to determine the exact ratio within the range of 1-for-5 to 1-for-15.

Industry Context

Reverse stock splits are sometimes used by companies to increase their stock price and maintain listing requirements on exchanges like Nasdaq.

Comparison to Industry Standards

• Reverse stock splits are a common corporate action, particularly for companies with low share prices.
• Other companies that have recently performed reverse stock splits include Cassava Sciences (1-for-5) and Faraday Future (1-for-80).
• The 1-for-10 ratio is within the typical range for reverse stock splits.

Stakeholder Impact

• Shareholders will have their number of shares reduced by a factor of 10, but the value of their holdings should remain the same immediately after the split.
• Shareholders will receive cash in lieu of fractional shares.
• The company's stock will trade on a split-adjusted basis.

Next Steps

• Stockholders will receive instructions from Equiniti Trust Company on how to exchange their pre-split shares for post-split shares.
• The company will notify stockholders holding shares in certificated form to transmit their old certificates to the transfer agent.
• The transfer agent will issue new certificates representing the appropriate number of whole shares of common stock following the reverse stock split.

Key Dates

Keywords

reverse stock split, stock split, common stock, TCRT, Alaunos Therapeutics, share consolidation, Equiniti Trust Company, Nasdaq